Czech Republic - Beta Blocking Medicine Use
Since 2014, Czech Republic Beta Blocking Medicine Use decreased by 0.8% year on year. In 2019, the country was number 7 comparing other countries in Beta Blocking Medicine Use at 62.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Czech Republic is overtaken by Finland, which was ranked number 6 at 63.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Latvia with 56.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Germany lead the ranking with 81.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 2.1% compared to 2018. Lithuania, Belgium and Hungary respectively ranked number 2, 3 and 4 in this ranking. Turkey witnessed the best average annual growth at +5% per year, while Chile witnessed the worst performance at -4.9% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 62.20 |
| 2018 | 61.50 |
| 2017 | 65.00 |
| 2016 | 64.10 |
| 2015 | 65.60 |
How does Czech Republic rank in Beta Blocking Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
82 | 2019 | +2.1 % | -1.6 % | View data | |
| 2 |
#2
Lithuania
|
77 | 2019 | +3.4 % | +1.6 % | View data | |
| 6 |
#6
Finland
|
63 | 2019 | -0.3 % | -1.8 % | View data | |
| 7 |
#7
Czech Republic
|
62 | 2019 | +1.1 % | -0.8 % | View data | |
| 8 |
#8
Latvia
|
57 | 2019 | +7.0 % | +4.0 % | View data | |